Crizotinib
-
Catalog number1934-25
-
PricePlease ask
-
Size25 mg
-
-
Alternative_name3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine
-
DescriptionA specific, ATP-competitive, small-molecule inhibitor of the receptor tyrosine kinases (RTKs) c-Met and anaplastic lymphoma kinase (ALK). Iinhibits tyrosine phosphorylation of activated ALK at nanomolar concentrations. Inhibits the growth and survival of cell lines dependent upon c-Met or ALK enzymatic activity.
-
CAS Number877399-52-5
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₁H₂₂Cl₂FN₅O
-
Molecular Weight450.34
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO
-
HandlingProtect from air and light
-
Tag LineA potent c-Met and ALK inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
MDL NumberMFCD12407409
-
PubChem CID11626560
-
SMILESCC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N
-
InChiInChI=1S/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m1/s1
-
InChi KeyKTEIFNKAUNYNJU-GFCCVEGCSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameCrizotinib
-
Alternative nameCrizotinib
-